Amarin Corporation PLC at H C Wainwright Global Investment Conference (Virtual) Transcript
Hello, everyone. I'm Andrew Fein, one of the biotechnology analysts at H.C. Wainwright. Thank you for coming. Glad to be back in-person.
So the next company presenting will be Amarin, and presenting for the company will be its President and CEO, Karim Mikhail. Thank you.
Thank you, Andrew. This is Karim Mikhail, President and CEO of Amarin. Today, my presentation may make some forward-looking statements. And of course, for all the list of risk factors, please do consult our SEC filing.
So at Amarin, we have a very focused growth strategy. Really, priority #1 is growing the VASCEPA business by stabilizing the U.S., launching successfully in Europe and expanding to international. And -- but also, we're also focusing, obviously, on managing the life cycle of VASCEPA. We have an incredible asset that we want to extend its life cycle and diversifying with BD
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
